Absence of renal lesions in C57BL/KaLwRij mice with advanced myeloma due to 5T2MM cells

Leukemia Research

Volumn 30, Issue 11, 2006, Pages 1371-1375

  Libouban, Hélène ^a   Onno, Céline ^a   Pascaretti Grizon, Florence ^a   Gallois, Yves ^a   Moreau, Marie Françoise ^a   Baslé, Michel F ^a   Chappard, Daniel ^a  

^a INSERM   (France)

Author keywords

5T2MM; Kidney; Myeloma; Osteolysis; Renal insufficiency

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INOCULATION; KIDNEY FAILURE; KIDNEY INJURY; LIGHT CHAIN; MOUSE; MULTIPLE MYELOMA; NONHUMAN; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; CELL LINE, TUMOR; CREATININE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; KIDNEY; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOPLASM TRANSPLANTATION; PARATHYROID HORMONE; TUMOR STEM CELLS;

EID: 33748093398     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.05.014     Document Type: Article

References (22)

1. Badros A., Barlogie B., Siegel E., Roberts J., Langmaid C., Zangari M., et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Brit J Haematol 114 (2001) 822-829
2. Blade J., Fernandez-Llama P., Bosch F., Montoliu J., Lens X.M., Montoto S., et al. Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158 (1998) 1889-1893
3. Callander N.S., and Roodman G.D. Myeloma bone disease. Semin Hematol 38 (2001) 276-285
4. Corso A., Zappasodi P., and Lazzarino M. Urinary proteins and renal dysfunction in patients with multiple myeloma. Biomed Pharmacother 56 (2002) 139-143
5. Decourt C., Rocca A., Bridoux F., Vrtovsnik F., Preud'homme J.L., Cogne M., et al. Mutational analysis in murine models for myeloma-associated Fanconi's syndrome or cast myeloma nephropathy. Blood 94 (1999) 3559-3566
6. Gado K., Silva S., Paloczi K., Domjan G., and Falus A. Mouse plasmacytoma: an experimental model of human multiple myeloma. Haematologica 86 (2001) 227-236
7. Herrera G.A. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions. Med Electron Microsc 34 (2001) 1-18
8. Herrera G.A. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory. Ann Diagn Pathol 4 (2000) 174-200
9. Horiuchi T., Miyachi T., Arai T., Nakamura T., Mori M., and Ito H. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma. Horm Metab Res 29 (1997) 469-471
10. Huang Y.W., Richardson J.A., Tong A.W., Zhang B.Q., Stone M.J., and Vitetta E.S. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Res 53 (1993) 1392-1396
11. Knudsen L.M., Hjorth M., and Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Europ J Haematol 65 (2000) 175-181
12. Libouban H., Moreau M.F., Baslé M., Bataille R., and Chappard D. Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2MM mouse model. Bone 33 (2003) 283-292
13. Libouban H., Moreau M.F., Baslé M.F., Bataille R., and Chappard D. Selection of a highly aggressive myeloma cell line by an altered bone microenvironment in the C57BL/KaLwRij mouse. Biochem Biophys Res Commun 316 (2004) 859-866
14. Libouban H., Moreau M.F., Lesourd M., Baslé M.F., and Chappard D. Osteolytic bone lesions in the 5T2 multiple myeloma model: radiographic, scanning electron microscopic and microtomographic studies. J Histotechnol 24 (2001) 81-86
15. Oba Y., Lee J.W., Ehrlich L.A., Chung H.Y., Jelinek D.F., Callander N.S., et al. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells. Exp Hematol 33 (2005) 272-278
16. Radl J., Croese J.W., Zurcher C., Van Den Enden-Vieveen M.H.M., and De Leeuw A.M. Animal model of human disease: multiple myeloma. Am J Pathol 132 (1988) 177-181
17. Radl J., De Glopper E., Schuit H.R.E., and Zurcher C. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol 122 (1979) 609-613
18. Sanders P.W., Herrera G.A., and Galla J.H. Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int 32 (1987) 851-861
19. Solomon A., Weiss D.T., and Pepys M.B. Induction in mice of human light-chain-associated amyloidosis. Am J Pathol 140 (1992) 629-637
20. Van Riet I. Homing mechanisms of myeloma cells. Pathol Biol (Paris) 47 (1999) 98-108
21. Vanderkerken K., De Greef C., Asosingh K., Arteta B., De Veerman M., Vande Broek I., et al. Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KaLwRij mouse. Brit J Cancer 82 (2000) 953-959
22. Vanderkerken K., De Raeve H., Van Meirvenne S., Radl J., Van Riet I., Thielemans K., et al. Organ involvement and phenotypic adhesion profile of the 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Brit J Cancer 76 (1997) 451-460